Singapore markets closed
Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,307.01 -14.40 (-0.27%) Dow
39,671.04 -201.95 (-0.51%) Nasdaq
16,801.54 -31.08 (-0.18%) Bitcoin USD
69,968.30 -89.59 (-0.13%) CMC Crypto 200
1,504.04 +1.38 (+0.09%)
Carisma Therapeutics, Inc. (CARM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.4200 |
| Open | 1.4400 |
| Bid | 1.3900 x 300 |
| Ask | 1.4200 x 200 |
| Day's range | 1.4000 - 1.4650 |
| 52-week range | 1.3450 - 9.7660 |
| Volume | |
| Avg. volume | 171,670 |
| Market cap | 58.575M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is There An Opportunity With Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 46% Undervaluation?
Key Insights The projected fair value for Carisma Therapeutics is US$2.77 based on 2 Stage Free Cash Flow to Equity...
- Zacks
Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates
CARISMA THERAP (CARM) delivered earnings and revenue surprises of -24.32% and 12.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
CARISMA THERAP (CARM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.